Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma
Christina Papanikolaou(National Hellenic Research Foundation), Amanda Psyrri(National and Kapodistrian University of Athens), Niki Gavrielatou(National and Kapodistrian University of Athens), Periklis Foukas(National and Kapodistrian University of Athens), David L. Rimm(Yale University), Μaria Anastasiou(National and Kapodistrian University of Athens), Aris Spathis(National and Kapodistrian University of Athens), Anastasios Kyriazoglou(Alexandra Hospital), George-Romanos P. Foukas(University General Hospital Attikon), Ioannis Kotsantis(National and Kapodistrian University of Athens), Vassilis L. Souliotis(National Hellenic Research Foundation), Myrto Moutafi(University General Hospital Attikon), Panagiota Economopoulou(National and Kapodistrian University of Athens), Ioannis M. Lelegiannis(National and Kapodistrian University of Athens), Ioannis G. Panayiotides(National and Kapodistrian University of Athens)
Cited by 6
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
|JAMA Oncology|2015|834
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753